Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$1.83 - $4.06 $44,547 - $98,832
-24,343 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$1.5 - $4.52 $36,514 - $110,030
24,343 New
24,343 $59,000
Q2 2019

Aug 14, 2019

SELL
$1.79 - $3.05 $17,900 - $30,500
-10,000 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$1.47 - $3.06 $14,700 - $30,600
10,000 New
10,000 $24,000

Others Institutions Holding SELB

About SELECTA BIOSCIENCES INC


  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.